Fig. 1From: Modified FOLFIRINOX versus gemcitabine plus oxaliplatin as first-line chemotherapy for patients with locally advanced or metastatic cholangiocarcinoma: a retrospective comparative studyProgression-free survival (A) and overall survival (B) in patients receiving mFOLFIRINOX (n = 27) and Gemox (n = 22)Back to article page